Connor, Clark & Lunn Investment Management (CC&L)’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,504	Closed	-$1.68M	–	1590
2025 Q3	$1.68M	Buy	+30,504	New	+$1.26M	0.01%	910
2024 Q2	–	Sell	-49,770	Closed	-$3.49M	–	1446
2024 Q1	$3.49M	Sell	49,770 -80,702	-62%	-$6.24M	0.02%	512
2023 Q4	$10.9M	Sell	130,472 -37,505	-22%	-$1.36M	0.05%	261
2023 Q3	$4.95M	Buy	167,977 +45,624	+37%	+$1.52M	0.03%	404
2023 Q2	$3.99M	Sell	122,353 -45,229	-27%	-$1.67M	0.02%	439
2023 Q1	$5.9M	Buy	167,582 +5,726	+4%	+$234K	0.03%	336
2022 Q4	$7.42M	Buy	161,856 +97,572	+152%	+$4.2M	0.04%	276
2022 Q3	$3.12M	Sell	64,284 -29,555	-31%	-$1.42M	0.02%	412
2022 Q2	$3.69M	Buy	93,839 +10,574	+13%	+$426K	0.02%	366
2022 Q1	$3.06M	Sell	83,265 -14,833	-15%	-$527K	0.02%	408
2021 Q4	$4.47M	Buy	+98,098	New	+$3.79M	0.02%	355
2014 Q2	–	Sell	-141,043	Closed	-$1.48M	–	551
2014 Q1	$1.48M	Sell	141,043 -61,300	-30%	-$554K	0.01%	317
2013 Q4	$1.4M	Buy	202,343 +113,193	+127%	+$744K	0.01%	316
2013 Q3	$694K	Buy	+89,150	New	+$956K	0.01%	316